SCHEMBL5580680

SCHEMBL5580680

CCC[C@H]1CC[C@H](c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.47
ALDH1A1 P00352 7/20 0.44
LMNA P02545 4/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
MAPK1 P28482 2/20 0.44
KMT2A Q03164 2/20 0.44
CA2 P00918 3/20 0.41
CA1 P00915 2/20 0.41
KDM4E B2RXH2 3/20 0.40
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
TYR P14679 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ESR2 Q92731 1/20 0.39
FYN P06241 1/20 0.39
TSHR P16473 2/20 0.38
RECQL P46063 1/20 0.37
ALOX15 P16050 2/20 0.37
HPN P05981 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9939522 1.00 CYP2C9 (0.47) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL17123615 0.95 CYP2C9 (0.43) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL19623181 0.91 CA2 (0.39) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL19628559 0.89 CA2 (0.38) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL19160572 0.89 CA2 (0.42) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL25693896 0.88 MAPT (0.38) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL25693895 0.88 MAPT (0.38) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL15445303 0.87 CYP2C9 (0.37) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL19677848 0.86 CA2 (0.54) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL17123614 0.86 CYP2C9 (0.50) CYP2C9ALDH1A1LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3980510-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2023-11-08 EP disclosed
US-11802243-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2023-10-31 US disclosed
US-11802243-B2 Liquid-crystal medium MERCK PATENT GMBH (DE) 2023-10-31 US disclosed
US-11762241-B2 Device for the regulation of light transmission MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
US-11762241-B2 Device for the regulation of light transmission MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
US-11667845-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
US-11667845-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
WO-2023094404-A1 LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2023-06-01 WO disclosed
US-20230053362-A1 DICHROIC DYE COMPOSITION MERCK PATENT GMBH (DE) 2023-02-23 US disclosed
WO-2023012202-A1 SWITCHING LAYERS FOR USE IN A WINDOW ELEMENT MERCK PATENT GMBH (DE) 2023-02-09 WO disclosed
EP-3839620-A1 DEVICE FOR THE REGULATION OF LIGHT TRANSMISSION Merck Patent GmbH (DE) 2021-06-23 EP disclosed
US-20210181585-A1 DEVICE FOR THE REGULATION OF LIGHT TRANSMISSION MERCK PATENT GMBH (DE) 2021-06-17 US disclosed
WO-2020245084-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-12-10 WO disclosed
EP-3529334-B1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2020-10-07 EP disclosed
WO-2020127141-A1 SWITCHING LAYERS FOR USE IN A SWITCHING ELEMENT MERCK PATENT GMBH (DE) 2020-06-25 WO disclosed
WO-2019238567-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-12-19 WO disclosed
US-20190316037-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-10-17 US disclosed
US-7166337-B2 Liquid-crystal composition, methods of adjusting the resistance, and substituted phenols MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2007-01-23 US disclosed
US-20020084444-A1 Liquid-crystal composition, methods of adjusting the resistance, and substituted phenols MERCK PATENT GESELLSCHAFT MIT (DE) 2002-07-04 US disclosed
US-6139925-A Liquid-crystal composition, method of adjusting the resistance, and substituted phenols MERCK PATENT GESELLSCHAFT MIT (DE) 2000-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667845-B2 Liquid crystalline medium NEFM, CCNI, MYT1 CYP2C9 887/4885ALDH1A1 1933/4885LMNA 885/4885
US-20020084444-A1 Liquid-crystal composition, methods of adjusting the resistance, and substituted phenols SLC11A2, RCC1, ABCC1 CYP2C9 210/4885ALDH1A1 1947/4885LMNA 966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.